Combination of a PD-1 antagonist and CpG-C type oligonucleotide for treating cancer Grant US-11918648-B2 United States of America 05 Mar 2024
PD-1 antibody, antigen-binding fragment thereof, and medical application thereof Grant US-11365255-B2 United States of America 21 Jun 2022
Anti-PD-1 antibodies and methods of use thereof Grant US-11345755-B2 United States of America 31 May 2022
Anti-PD-1 antibodies and methods of use thereof Grant US-10450373-B2 United States of America 22 Oct 2019